Prevalence of neuropathic pain in patients with cancer
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | BrJP (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922018000300231 |
Resumo: | ABSTRACT BACKGROUND AND OBJECTIVES: To evaluate the prevalence and factors associated with neuropathic pain in cancer patients METHODS: A prospective cross-sectional study conducted from August 2016 to July 2017, with 267 cancer patients above 18 years of age, with pain. Diabetic patients and patients with previous chronic pain unrelated to the current neoplasia were excluded. The demographic and disease information was obtained from the medical records and directly with the patient. The Douleur Neuropathique en 4 questions questionnaire and the numeric pain scale were later applied. RESULTS: The prevalence of neuropathic pain in the study population was 53%. The average age of patients was 55.3 years. Of the 267 patients, 76% were female. There was no significant difference in the occurrence of neuropathic pain among gender, age, histological type of cancer and type of treatment. Of the patients, 35.5% who underwent chemotherapy had neuropathic pain, and there was no statistical difference between the types of chemotherapy performed. Twenty-four patients who reported pain at the radiotherapy site were diagnosed with neuropathic pain. Of the total, 63 patients who reported pain at the surgical site, 36 were classified with neuropathic pain. An increasing trend of neuropathic pain was observed when treatments were associated. The intensity of this pain was reported as moderate to severe by the majority of patients in the various types of treatment: chemotherapy, radiotherapy, and surgery. CONCLUSION: When compared to other studies, a high prevalence of neuropathic pain was observed in more than half of the patients evaluated. |
id |
SBED-2_275fbda8c903b01d6808e0abe30b7973 |
---|---|
oai_identifier_str |
oai:scielo:S2595-31922018000300231 |
network_acronym_str |
SBED-2 |
network_name_str |
BrJP (Online) |
repository_id_str |
|
spelling |
Prevalence of neuropathic pain in patients with cancerChemotherapyDouleur Neuropathique en 4 questionsNeuropathic painOncologic painPainABSTRACT BACKGROUND AND OBJECTIVES: To evaluate the prevalence and factors associated with neuropathic pain in cancer patients METHODS: A prospective cross-sectional study conducted from August 2016 to July 2017, with 267 cancer patients above 18 years of age, with pain. Diabetic patients and patients with previous chronic pain unrelated to the current neoplasia were excluded. The demographic and disease information was obtained from the medical records and directly with the patient. The Douleur Neuropathique en 4 questions questionnaire and the numeric pain scale were later applied. RESULTS: The prevalence of neuropathic pain in the study population was 53%. The average age of patients was 55.3 years. Of the 267 patients, 76% were female. There was no significant difference in the occurrence of neuropathic pain among gender, age, histological type of cancer and type of treatment. Of the patients, 35.5% who underwent chemotherapy had neuropathic pain, and there was no statistical difference between the types of chemotherapy performed. Twenty-four patients who reported pain at the radiotherapy site were diagnosed with neuropathic pain. Of the total, 63 patients who reported pain at the surgical site, 36 were classified with neuropathic pain. An increasing trend of neuropathic pain was observed when treatments were associated. The intensity of this pain was reported as moderate to severe by the majority of patients in the various types of treatment: chemotherapy, radiotherapy, and surgery. CONCLUSION: When compared to other studies, a high prevalence of neuropathic pain was observed in more than half of the patients evaluated.Sociedade Brasileira para o Estudo da Dor2018-07-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922018000300231BrJP v.1 n.3 2018reponame:BrJP (Online)instname:Sociedade Brasileira para o Estudo da Dor (SBED)instacron:SBED10.5935/2595-0118.20180045info:eu-repo/semantics/openAccessCouceiro,Tania Cursino de MenezesLima,Luciana CavalcantiCoutinho Júnior,Mário PereiraMello,Pedro Filipe da Luz Siqueira de OliveiraFerreira,Thaysi Maria Mendonça LopesFirmino,Ana Lígia Pereiraeng2018-09-12T00:00:00Zoai:scielo:S2595-31922018000300231Revistahttps://sbed.org.br/publicacoes-publicacoes-bjp/ONGhttps://old.scielo.br/oai/scielo-oai.phpdkt@terra.com.br || dor@dor.org.br2595-31922595-0118opendoar:2018-09-12T00:00BrJP (Online) - Sociedade Brasileira para o Estudo da Dor (SBED)false |
dc.title.none.fl_str_mv |
Prevalence of neuropathic pain in patients with cancer |
title |
Prevalence of neuropathic pain in patients with cancer |
spellingShingle |
Prevalence of neuropathic pain in patients with cancer Couceiro,Tania Cursino de Menezes Chemotherapy Douleur Neuropathique en 4 questions Neuropathic pain Oncologic pain Pain |
title_short |
Prevalence of neuropathic pain in patients with cancer |
title_full |
Prevalence of neuropathic pain in patients with cancer |
title_fullStr |
Prevalence of neuropathic pain in patients with cancer |
title_full_unstemmed |
Prevalence of neuropathic pain in patients with cancer |
title_sort |
Prevalence of neuropathic pain in patients with cancer |
author |
Couceiro,Tania Cursino de Menezes |
author_facet |
Couceiro,Tania Cursino de Menezes Lima,Luciana Cavalcanti Coutinho Júnior,Mário Pereira Mello,Pedro Filipe da Luz Siqueira de Oliveira Ferreira,Thaysi Maria Mendonça Lopes Firmino,Ana Lígia Pereira |
author_role |
author |
author2 |
Lima,Luciana Cavalcanti Coutinho Júnior,Mário Pereira Mello,Pedro Filipe da Luz Siqueira de Oliveira Ferreira,Thaysi Maria Mendonça Lopes Firmino,Ana Lígia Pereira |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Couceiro,Tania Cursino de Menezes Lima,Luciana Cavalcanti Coutinho Júnior,Mário Pereira Mello,Pedro Filipe da Luz Siqueira de Oliveira Ferreira,Thaysi Maria Mendonça Lopes Firmino,Ana Lígia Pereira |
dc.subject.por.fl_str_mv |
Chemotherapy Douleur Neuropathique en 4 questions Neuropathic pain Oncologic pain Pain |
topic |
Chemotherapy Douleur Neuropathique en 4 questions Neuropathic pain Oncologic pain Pain |
description |
ABSTRACT BACKGROUND AND OBJECTIVES: To evaluate the prevalence and factors associated with neuropathic pain in cancer patients METHODS: A prospective cross-sectional study conducted from August 2016 to July 2017, with 267 cancer patients above 18 years of age, with pain. Diabetic patients and patients with previous chronic pain unrelated to the current neoplasia were excluded. The demographic and disease information was obtained from the medical records and directly with the patient. The Douleur Neuropathique en 4 questions questionnaire and the numeric pain scale were later applied. RESULTS: The prevalence of neuropathic pain in the study population was 53%. The average age of patients was 55.3 years. Of the 267 patients, 76% were female. There was no significant difference in the occurrence of neuropathic pain among gender, age, histological type of cancer and type of treatment. Of the patients, 35.5% who underwent chemotherapy had neuropathic pain, and there was no statistical difference between the types of chemotherapy performed. Twenty-four patients who reported pain at the radiotherapy site were diagnosed with neuropathic pain. Of the total, 63 patients who reported pain at the surgical site, 36 were classified with neuropathic pain. An increasing trend of neuropathic pain was observed when treatments were associated. The intensity of this pain was reported as moderate to severe by the majority of patients in the various types of treatment: chemotherapy, radiotherapy, and surgery. CONCLUSION: When compared to other studies, a high prevalence of neuropathic pain was observed in more than half of the patients evaluated. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-07-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922018000300231 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922018000300231 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.5935/2595-0118.20180045 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira para o Estudo da Dor |
publisher.none.fl_str_mv |
Sociedade Brasileira para o Estudo da Dor |
dc.source.none.fl_str_mv |
BrJP v.1 n.3 2018 reponame:BrJP (Online) instname:Sociedade Brasileira para o Estudo da Dor (SBED) instacron:SBED |
instname_str |
Sociedade Brasileira para o Estudo da Dor (SBED) |
instacron_str |
SBED |
institution |
SBED |
reponame_str |
BrJP (Online) |
collection |
BrJP (Online) |
repository.name.fl_str_mv |
BrJP (Online) - Sociedade Brasileira para o Estudo da Dor (SBED) |
repository.mail.fl_str_mv |
dkt@terra.com.br || dor@dor.org.br |
_version_ |
1754732509495558144 |